KRISTAL LANG: Open Payments
NPI 1487132171 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,446 in 69 payments from 19 companies in 2025. Trend: 2023 $625 · 2024 $953 · 2025 $1,446
Food & beverage: $1,446
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 15 | $280 |
| Corium, LLC | 16 | $276 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $151 |
| Teva Pharmaceuticals USA, Inc. | 4 | $100 |
| Alkermes, Inc. | 4 | $79 |
| Vanda Pharmaceuticals Inc. | 3 | $79 |
| Neurocrine BioSciences, Inc. | 4 | $78 |
| Janssen Pharmaceuticals, Inc | 3 | $75 |
| Axsome Therapeutics, Inc. | 3 | $66 |
| ABBVIE INC. | 2 | $51 |
Products named: REXULTI, Azstarys, CAPLYTA, ARISTADA, INGREZZA, Auvelity, UZEDY, VRAYLAR.
Industry payments across KS — which companies pay providers there.
